We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Despite a series of positive intellectual property reforms in recent years, sources at the Mexican unit of US-based drug maker Pfizer have highlighted the heavy toll taken on multinationals by pirated medicines.
Estonia's Ministry of Social Affairs has announced that it will seek EEK50mn (US$3.93mn) in additional funding in 2006 to combat HIV/AIDS in the country.
Ranbaxy Laboratories Ltd on Thursday announced that, its wholly owned subsidiary, Ranbaxy Pharmaceuticals Inc. (RPI), USA, has received the coveted Supplier Quality Award from Cardinal Health, for services, that supported the Cardinal Health pharmaceutical distribution, organization.
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and iCo Therapeutics Inc. announced today that Isis has granted an exclusive worldwide license to iCo for the development and commercialization of ISIS 13650, a second-generation antisense drug.
India has requested the European Union (EU) to exclude ayurvedic products from the proposed directive on traditional herbal medicinal products (THMPD).
The manufacturers' selling price (MSP) of pharmaceuticals produced and sold in South Africa dropped 2.1% in June 2005 compared to the same period last year.